发明名称 Phosphinate based inhibitors of matrix metalloproteases
摘要 A compound of the formula wherein R1, R2, R3, R4, R5, R6 and Ar are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, synergy with cytotoxic anticancer agents, tissue ulceration, macular degeneration, restenosis, periodontal disease, epidermolysis bullosa, scleritis, in combination with standard NSAID'S and analgesics and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock and other diseases involving the production of TNF. In addition, the compounds of the present invention may be used in combination therapy with standard non-steroidal anti-inflammatory drugs (NSAID'S) and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinim, etoposide, taxol, taxotere and other alkaloids, such as vincristine, in the treatment of cancer.
申请公布号 ZA9706330(B) 申请公布日期 1999.01.19
申请号 ZA19970006330 申请日期 1997.07.17
申请人 PFIZER INC. 发明人 LAWRENCE ALAN REITER
分类号 A61K31/66;A61K31/00;A61P1/00;A61P1/02;A61P9/00;A61P17/00;A61P25/04;A61P29/00;A61P31/00;A61P31/02;A61P31/18;A61P35/00;A61P43/00;C07F9/30;C07F9/36;C07F9/58;C07F9/655;C07F9/6553 主分类号 A61K31/66
代理机构 代理人
主权项
地址